Iradimed (IRMD) Gains from Sales and Divestitures (2017 - 2025)
Iradimed (IRMD) reported Gains from Sales and Divestitures of $63105.0 for Q4 2025, up 23.57% year-over-year from $51069.0 in Q4 2024, and up 23.57% quarter-over-quarter from $51069.0 in Q4 2024.
Iradimed (IRMD) Gains from Sales and Divestitures (2017 - 2025) Analysis & Trends
Iradimed (IRMD) has 9 years of Gains from Sales and Divestitures data on file, last reported at $63105.0 in Q4 2025.
- Gains from Sales and Divestitures for Q4 2025 came in at $63105.0, up 23.57% year-over-year; the trailing twelve-month figure through Dec 2025 was $63105.0 (up 23.57% YoY), and the FY2025 annual result was $63105.0, up 23.57% from the prior year.
- Gains from Sales and Divestitures climbed to $63105.0 in Q4 2025 per IRMD's latest filing, from $51069.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $63105.0 in Q4 2025 and troughed at $4252.0 in Q4 2023.
- A 5-year average of $43566.8 and a median of $51069.0 in 2024 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2023 and 2024: Gains from Sales and Divestitures tumbled 89.57% in 2023, then jumped 1101.06% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $58650.0 in 2021, then slumped by 30.51% to $40758.0 in 2022, then plunged by 89.57% to $4252.0 in 2023, then jumped by 1101.06% to $51069.0 in 2024, then grew by 23.57% to $63105.0 in 2025.
- Business Quant data shows IRMD's Gains from Sales and Divestitures at $63105.0 in Q4 2025, $51069.0 in Q4 2024, and $4252.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Iradimed | 1.18 Bn | 1.12 Bn | 16.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 63,105.00 |
| Dec 31, 2025 | 63,105.00 |
| Dec 31, 2024 | 51,069.00 |
| Dec 31, 2024 | 51,069.00 |
| Dec 31, 2023 | 4,252.00 |
| Dec 31, 2023 | 4,252.00 |
| Dec 31, 2022 | 40,758.00 |
| Dec 31, 2022 | 40,758.00 |
| Dec 31, 2021 | 58,650.00 |
| Dec 31, 2021 | 58,650.00 |
| Dec 31, 2020 | 9,345.00 |
| Dec 31, 2020 | 9,345.00 |
| Sep 30, 2020 | 139,890.00 |
| Sep 30, 2020 | 139,890.00 |
| Jun 30, 2020 | 128,878.00 |
| Jun 30, 2020 | 128,878.00 |
| Mar 31, 2020 | 19,844.00 |
| Mar 31, 2020 | 19,844.00 |
| Dec 31, 2019 | 93,989.00 |
| Dec 31, 2019 | 93,989.00 |